Neonatal Thrombocytopenia
On this page
Direct answer
Neonatal thrombocytopenia is a platelet count below 150 × 10⁹/L, affecting roughly one to two per cent of term newborns but up to a quarter of neonatal intensive care admissions. The decisive clinical tool is timing: platelets low within the first 72 hours point to placental insufficiency (growth restriction, maternal hypertension, diabetes), perinatal asphyxia, or immune-mediated destruction from maternal antibody; thrombocytopenia after 72 hours is sepsis, necrotising enterocolitis or congenital infection until proven otherwise. Severity drives urgency, because the neonate's bleeding risk climbs steeply below 30 × 10⁹/L. Neonatal alloimmune thrombocytopenia — maternal antibody against a fetal platelet antigen the mother lacks — produces the severest counts with a normal maternal platelet count, and remains the diagnosis to catch, since about one in ten affected fetuses suffers intracranial haemorrhage.
What you must remember
- Definitions: platelets under 150 × 10⁹/L; mild 100 to 150, moderate 50 to 100, severe below 50 × 10⁹/L; a well term baby with isolated mild thrombocytopenia that resolves in days is usually benign.
- Early onset (under 72 hours): chronic fetal hypoxia from pre-eclampsia, intrauterine growth restriction or maternal diabetes is the commonest cause; others are birth asphyxia, neonatal alloimmune thrombocytopenia, maternal immune thrombocytopenia and thrombosis (renal vein, aorta).
- Late onset (after 72 hours): late-onset sepsis and necrotising enterocolitis dominate; also TORCH infections (especially CMV), rubella, and drugs; a sick preterm baby whose platelets crash should prompt sepsis evaluation, not just repeat counting.
- Neonatal alloimmune thrombocytopenia (NAIT): mother is HPA-1a negative and makes anti-HPA-1a against HPA-1a-positive fetal platelets — the platelet counterpart of haemolytic disease of the newborn, but the firstborn is commonly affected (unlike Rh disease); maternal platelet count is normal, neonatal platelets are often below 30 × 10⁹/L, and intracranial haemorrhage threatens around 10 per cent.
- Autoimmune (maternal ITP): IgG crosses the placenta, but neonatal counts are usually only mildly low (maternal count also low) and severe bleeding is rare — the mirror image of NAIT and a favourite comparison question.
- Congenital infection and marrow failure clues: CMV, rubella and toxoplasmosis with hepatosplenomegaly, petechiae and "blueberry muffin" purpura; absent radii (thrombocytopenia-absent radius syndrome), Fanconi anaemia, Wiskott-Aldrich (eczema, immunodeficiency, tiny platelets) and transient myeloproliferative disorder in Down syndrome.
- Transfusion thresholds (commonly quoted): prophylactic platelets below 20 × 10⁹/L in a stable neonate, below 30 in a sick or unstable one, and below 50 with active bleeding, before surgery or with intracranial haemorrhage risk — NAIT is treated with IVIG plus antigen-negative platelets; workup pairs a full blood count and film with the maternal platelet count and a sepsis screen.
A case that teaches the timing logic
A term boy, birth weight on the 3rd centile to a mother with pregnancy-induced hypertension, is noted at 12 hours to have scattered petechiae and gastric bleeding; platelets are 28 × 10⁹/L. Placental insufficiency thrombocytopenia usually lands between 50 and 100, so this severity forces the immune causes onto the table. The mother's platelet count is 240 × 10⁹/L — normal, which quietly excludes maternal ITP and argues for NAIT. Management is two-track: haemostatic (IVIG 1 g/kg with antigen-negative platelets if available, otherwise random platelets plus IVIG, and a cranial ultrasound looking for haemorrhage) and diagnostic (platelet antigen genotyping of mother and father). The next pregnancy matters: NAIT recurs and can be worse, so future pregnancies are monitored with fetal platelet counts and maternal IVIG.
Contrast this with a 26-week preterm who at day 10 develops abdominal distension, feed intolerance and a platelet fall from 180 to 40 × 10⁹/L — necrotising enterocolitis until an abdominal film says otherwise; the platelet count here is a barometer of the illness, and the treatment is of the bowel, not the marrow.
How the exam frames it
The commonest single question pairs a severely thrombocytopenic neonate with a normal maternal platelet count and expects NAIT; the same stem with a low maternal count and a history of easy bruising in the mother expects maternal ITP, and the expected answer about severity is that NAIT is the dangerous one. The second favourite is the day-10 preterm collapse — sepsis or necrotising enterocolitis. Examiners also reward anyone who says out loud that a neonate with a platelet count under 30 × 10⁹/L needs a cranial ultrasound, because intracranial haemorrhage is the complication that changes outcome, and one that can be present before any external bleeding appears.
Frequently asked questions
What platelet count defines neonatal thrombocytopenia?
A count below 150 × 10⁹/L in any newborn, graded mild 100 to 150, moderate 50 to 100 and severe below 50 × 10⁹/L.
How is neonatal alloimmune thrombocytopenia distinguished from maternal ITP?
NAIT has a normal maternal platelet count with severe neonatal thrombocytopenia, whereas maternal ITP shows maternal thrombocytopenia with usually mild neonatal involvement.
Which organisms and conditions dominate late-onset neonatal thrombocytopenia?
Late-onset sepsis and necrotising enterocolitis, followed by congenital CMV and other TORCH infections.
At what platelet count is prophylactic transfusion generally given in a stable neonate?
Around 20 × 10⁹/L, raised to 30 in sick infants and 50 with active bleeding, prior to procedures or established intracranial haemorrhage.
Which congenital syndrome combines thrombocytopenia with absent radii?
Thrombocytopenia-absent radius (TAR) syndrome, where both forearms are absent but thumbs are present — the detail separating it from Fanconi anaemia.